Clinical Trials Directory

Trials / Completed

CompletedNCT04789421

Advanced Non-invasive Diagnostics for Early Cutaneous Tumor Diagnosis, Clinical-therapeutic and Economic Management

Multicenter, Randomised Study of the Impact of Advanced, Non-invasive Diagnostic Instrumentation for Early Cutaneous Tumor Diagnosis, Clinical-therapeutic Pathways and an Economic-management Perspective

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
3,248 (actual)
Sponsor
Azienda Ospedaliero-Universitaria di Modena · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The incidence of cutaneous melanoma (MM) is increasing worldwide. The best therapeutical solution for MM is early diagnosis and efforts over the last 50 years have been directed towards early and precise diagnoses. Dermoscopy has improved diagnostic accuracy compared to the naked eye, but is limited by an associated higher number of unnecessary excisions. Reflectance confocal microscopy (RCM) is a novel technique enabling in vivo examination of the skin at cellular-level resolution, with excellent diagnostic accuracy. This study hypothesis is that the systematic application of RCM in the triage and management of patients suspicious for skin cancer, may improve diagnostic accuracy and reduce the number of unnecessary biopsy. Reducing the burden of unnecessary surgery excisions should benefit the health system, both in saving surgical and pathology procedural associated costs and reducing the overwhelming waiting lists for excisions and consequent risk for delayed diagnoses.

Conditions

Interventions

TypeNameDescription
DEVICEClinical, dermoscopy and Reflective confocal microscopy evaluationsAdjunctive reflective confocal microscopy to dermoscopy and clinical dermatological evaluation.
DEVICEClinical, dermoscopy evaluationsDermoscopy and clinical dermatological evaluation only

Timeline

Start date
2016-03-01
Primary completion
2020-02-28
Completion
2020-03-16
First posted
2021-03-09
Last updated
2021-03-09

Regulatory

Source: ClinicalTrials.gov record NCT04789421. Inclusion in this directory is not an endorsement.